Golden_Brown The head of Pfizer's ( NYSE: PFE ) operations in China said the global pharmaceutical company will invest $1B in China from 2025-2030 as part of a program to boost drug R&D in the country. Pfizer China President Jean-Christophe Pointeau recently said the.
Back to Health Page
